Overall rank by patents
#20,983
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
According to USPTO PatentsView, Cytrellis ranks #20,983 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R20983 · US Corporation #20,983 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Crunchlabs Llc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Cytrellis Biosystems · this assignee
38 score
3D Lighting Innovati… · lowest
7 score
What this shows Cytrellis's Innovation Score is 37.8/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Cytrellis Biosystems, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 92.3% of grants classified under A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2017. By volume, Cytrellis sits between Crunchlabs Llc and DAJ Global Partners Llc.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CrunchLabs LLC
13 patents
Curbell Medical Products, Inc.
13 patents
Currax Pharmaceuticals LLC
13 patents
Cyboenergy, Inc.
13 patents
D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
13 patents
D.T. Davis Enterprises, Ltd.
13 patents
DAIICHI SANKYO EUROPE GMBH
13 patents
DAJ GLOBAL PARTNERS LLC
13 patents
Cytrellis Biosystems, Inc.
13 patents
What this shows Cytrellis holds 13 patents at rank #20,982, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,982 in granted patent volume.
Other assignees with the most granted patents in Cytrellis's primary technology class.
Cytrellis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 43% higher than 57% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 7.7% |
| 2019 | 1 | 7.7% |
| 2020 | 2 | 15.4% |
| 2021 | 2 | 15.4% |
| 2022 | 3 | 23.1% |
| 2024 | 3 | 23.1% |
| 2025partial year | 1 | 7.7% |
Top 4 of 4 technology areas
Overall rank by patents
#20,983
of 50,000 tracked assignees
37.8 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.